Matthew Rousculp, PhD, MPH is the Director of Comparative Effectiveness Research & Health Policy Research at GlaxoSmithKline. Matt has over 11 years of industry experience in pharmaceuticals and biologics, including U.S. and global roles. Matt has published over 40 manuscripts and book chapters.
SPEAKER
(S):
Lori Frank, PhD (SPKNON), Senior Research Scientist; Deputy Director, Center for Health Outcomes Research, United BioSource Corporation, United States
Dr. Frank is Dir., Engagement Research, at PCORI, focusing on bringing the patient perspective to CER & evaluating research engagement strategies. Her research centers on psychiatric disorders, & she serves on the Memory Screening Advisory Board of the Alzheimer's Foundation of America.
Troy Trygstad, PhD,MBA (SPKSUP), Vice President, Pharmacy Programs, Community Care of North Carolina, United States
Alan Menius, (SPKNON), Senior Director, Medical Analytics, GlaxoSmithKline, United States
Alan Menius is a Sr Dir in GSK’s Quantitative Sciences division where he is head of Medical Analytics. He & his team are currently progressing initiatives that use disparate data sources & advanced analytics to inform patients & their stakeholders on the safety & effectiveness of medicines.
Description
The speakers in this session will highlight patient-centered predictive models using diverse information sources that can be readily used by patients, providers and other key stakeholders.